Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Helsinn Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Helsinn Therapeutics (United States) is a research organisation in Iselin, US. OpenAlex records 129 works and 13,871 citations for it. 30 researchers list it as their most recent affiliation.

129
Works
13,871
Citations
30
Researchers
33
Avg h-index

How has Helsinn Therapeutics (United States)'s publication output changed over time?

ScholarIQpublication output · 2005–2020

Output grew0% over the shown period — from 1 works in 2005 to 1 in 2020.

1
1
1
1
1
2
2
1
1
200520062008201220142016201720182020

Who are the most-cited researchers behind Helsinn Therapeutics (United States)?

ScholarIQtop researchers by citations
1
Winnie W. Nelson · Atrial Fibrillation Management and Outcomes
150 works4,114 citations

What are the most-cited papers on Helsinn Therapeutics (United States)?

ScholarIQmost cited works
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
J. Bradford Rice, Alan G. White, Lauren M. Scarpati, George J. Wan, Winnie W. Nelson
Clinical Therapeutics. 2017575 CitationsOPEN ACCESS
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Scott D. Berkowitz, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A.A. Fox, Robert M. Califf, J. Anderson, Noel W. Bedwell, Martin Bilsker, G. Keith Bruce, Ramtin Agah, M Desantis, Steven Eisenberg, A. Flores, Wolfgang Herzog, S Klein, H. Snyder, Steven K. Krueger, Erasmo de la Peña-Almaguer, EFI LAVIE, C. Lee, G. Mallis, Manish Modi, Graeme F. Woodworth, I. Niazi, Brenda Peart, Sri Sundaram, Brian Snoddy, Rodolfo Sotolongo, John B. Moloney, Kris Vijayaraghavan, F. Whittier, L. Yellen, Subhash Banerjee, Daniel L. Lustgarten, Dr.S Suresh, M. Gelernt, L Levinson, R. Ghanekar, G. Larsen Kneller, Christian Hall, Yazid Y. Fadl, Mark J. Pirwitz, William J. French, Nolan Mayer, Jian Bianca Pugeda, Kevin Steel, Freny Vaghaiwalla Mody, Amir Malik, H. Chandna, Alan S. Go, George Emlein, William W Bowden, Roberto Moscoso, Ruth Hodson, Michael Berk, Dengji Pan, Janine Pappas, Robert C. Orchard, G. Lynchard, Nampalli Vijay, Waqor Khan, Maher Khadra, Mark C Antonishen, Fred Cucher, Michael E. Staab, James S. Zebrack, S Borromeo, Jacqueline M. Heilman, Seemant Chaturvedi, Sravya Makam, Samir Turk, Thomas M. Hyers, George W. Williams, Ajay Labroo, SK Gill, Donald W. Myears, Jean Marc Weinstein, Jeffrey G. Shanes, Y. Chandrashekhar, Surbhi Shah, William M. Reiter, Tim Logemann, Adrian K. Almquist, Ravi Bhagwat, Tahir Tak, J. Shen‐Ling, Priyesh Patel, Andre Artis, Amy Arouni
Journal of the American Heart Association. 2016200 CitationsOPEN ACCESS
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
François Laliberté, Michel Cloutier, Winnie W. Nelson, Craig I Coleman, Dominic Pilon, William H. Olson, C.V. Damaraju, Jeffrey Schein, Patrick Lefèbvre
Current Medical Research and Opinion. 2014185 Citations
Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis
Alok A. Khorana, Keith R. McCrae, Dejan Milentijevic, Jonathan Fortier, Winnie W. Nelson, François Laliberté, Concetta Crivera, Patrick Lefèbvre, Daniel Yannicelli, Jeff Schein
S4210185368. 2017141 CitationsOPEN ACCESS
Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Alok A. Khorana, Daniel Yannicelli, Keith R. McCrae, Dejan Milentijevic, Concetta Crivera, Winnie W. Nelson, Jeffrey Schein
Thrombosis Research. 2016139 Citations

How much of the research on Helsinn Therapeutics (United States) is open access?

ScholarIQopen access share
45%OPEN ACCESS
Gold
27%
Green
0%
Hybrid
18%
Bronze
0%
Closed
55%

Related on ScholarIQ

Nausea and vomiting management
Top Topic
Nutrition and Health in Aging
Top Topic
Adipose Tissue and Metabolism
Top Topic
Regulation of Appetite and Obesity
Top Topic
Cutaneous lymphoproliferative disorders research
Top Topic
Chemotherapy-induced organ toxicity mitigation
Top Topic
470M+ articles · free account